Metropolitan Life Insurance Company (MetLife)’s Mineralys Therapeutics MLYS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-1,238	Closed	-$16K	–	1288
2024 Q1	$16K	Hold	1,238	–	–	﹤0.01%	1959
2023 Q4	$10.6K	Buy	1,238 +511	+70%	+$4.4K	﹤0.01%	2159
2023 Q3	$6.91K	Hold	727	–	–	﹤0.01%	2361
2023 Q2	$12.4K	Buy	+727	New	+$12.4K	﹤0.01%	2184